CCM
LSTA icon

Connective Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Connective Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45K Hold
1,016
– – ﹤0.01% 69
2026
Q1 		$5.09K Hold
1,016
– – ﹤0.01% 63
2025
Q4 		$1.89K Hold
1,016
– – ﹤0.01% 57
2025
Q3 		$2.66K Buy
+1,016
New +$2.55K ﹤0.01% 72

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Connective Capital Management's LSTA Position: Q2 2026 in Review

Connective Capital Management held its Lisata Therapeutics (LSTA) position steady in Q2 2026 at 1,016 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #69.

Connective Capital Management first reported a position in LSTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.09K in Q1 2026. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Connective Capital Management held 1,016 shares of Lisata Therapeutics worth $3.45K as of Q2 2026.
  • Connective Capital Management left its Lisata Therapeutics share count unchanged in Q2 2026.
  • Lisata Therapeutics made up ﹤0.01% of Connective Capital Management's portfolio in Q2 2026, its #69 holding.
  • Connective Capital Management first reported a position in Lisata Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Connective Capital Management's Lisata Therapeutics position peaked at $5.09K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Connective Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.